Trial 6B-16-1


Evaluation of Regional Gadolinium Retention in the Brain using QSM with Correlation To Regional DCE MRI Permeability using GOCART Technique in Intracranial Neoplasm Patients Receiving Gadobenate Dimeglumine (MultiHance) or Gadoterate Meglumine (Dotarem)

Type: Other
Phase: Not Applicable
Status: Not Open (Closed)
Treatments: Radiation: Other
Randomized: Yes
USC Satellite Location: None
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Alexander Lerner, M.D.
Other Trial Staff:  Darryl Hwang, D.M., Rosaura Diaz, Coordinator

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.